Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alice S. van Velzen
Product Type and the Risk of Inhibitor Development in Nonsevere Haemophilia a Patients: A Case-Control Study
British Journal of Haematology
Hematology
Related publications
HLA-DRB1–factor VIII Binding Is a Risk Factor for Inhibitor Development in Nonsevere Hemophilia: A Case-Control Study
Blood advances
Hematology
An Update on the ‘Danger Theory‘ in Inhibitor Development in Haemophilia A
Expert Review of Hematology
Hematology
In Non-Severe Hemophilia a the Risk of Inhibitor After Intensive Factor Treatment Is Greater in Older Patients: A Case-Control Study
Journal of Thrombosis and Haemostasis
Medicine
Hematology
Inhibitor Development in Non-Severe Haemophilia Across Europe
Thrombosis and Haemostasis
Hematology
Psy223 - Qualitative Research in Haemophilia A: Emicizumab Transforms Lifestyle of Patients With Inhibitor
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Acute Abdomen in a Patient With Haemophilia A: A Case Study
International Archives of Medicine
Study of Serum Magnesium Levels in Type I Diabetes Mellitus Patients: A Case Control Study
Pediatric Review: International Journal of Pediatric Research
Risk Management in Medical Product Development Process Using Traditional FMEA and Fuzzy Linguistic Approach: A Case Study
Journal of Industrial Engineering International
Industrial
Manufacturing Engineering
Reconfirmation of Newly Discovered Risk Factors of Diabetic Peripheral Neuropathy in Patients With Type 2 Diabetes: A Case-Control Study
PLoS ONE
Multidisciplinary